✦ LIBER ✦

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

✍ Scribed by Belinda Thewes; Bettina Meiser; Vlatka M Duric; Martin R Stockler; Alan Taylor; Robin Stuart-Harris; Matthew Links; Nicholas Wilcken; Sue Anne McLachlan; Kelly-Anne Phillips; Jane Beith; Frances Boyle; Michael L Friedlander

Book ID: 117783579
Publisher: The Lancet
Year: 2005
Tongue: English
Weight: 102 KB
Volume: 6
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(05)70254-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patients’ preferences for adjuvant endoc

Patients’ preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?

✍ Duric, V M; Fallowfield, L J; Saunders, C; Houghton, J; Coates, A S; Stockler, M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

How much improvement in survival do earl

How much improvement in survival do early breast cancer patients require to consider endocrine therapy worthwhile?

✍ D. Fellowes; L.J. Fallowfield; C. Saunders; J. Houghton; A. Coates 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 167 KB

A Question of Duration: Do Patients with

A Question of Duration: Do Patients with Early-Stage Breast Cancer Need More Than Five Years of Adjuvant Endocrine Therapy?

✍ Susan Burdette-Radoux; Hyman B. Muss 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 106 KB